ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy

(2023) Lavanya Sivapalan et al.   Journal for ImmunoTherapy of Cancer

Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies

(2023) Mark D. Stewart et al.   Journal for ImmunoTherapy of Cancer

Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer

(2023) Lavanya Sivapalan et al.   CLINICAL CANCER RESEARCH

Automated next-generation profiling of genomic alterations in human cancers

(2022) Laurel A. Keefer et al.   Nature Communications

Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy

(2022) Michael Hwang et al.   Journal for ImmunoTherapy of Cancer

Metastatic colorectal cancer treatment response evaluation by ultra-deep sequencing of cell-free DNA and matched white blood cells

(2022) Iris van 't Erve et al.   CLINICAL CANCER RESEARCH

Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy

(2022) Valsamo Anagnostou et al.   Science Translational Medicine

The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer

(2021) Saya Jacob et al.   CLINICAL CANCER RESEARCH

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma

(2021) Justin M. Burgener et al.   CLINICAL CANCER RESEARCH

Next-Generation Sequencing Concordance Analysis of Comprehensive Solid Tumor Profiling between a Centralized Specialty Laboratory and the Decentralized Personal Genome Diagnostics, Inc., Elio Tissue Complete Kitted Solution

(2021) Kristen Lee Deak et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Validation of a Circulating Tumor DNA ‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing

(2021) Wael Al Zoughbi et al.   ONCOLOGIST

Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC

(2020) Matthew D. Hellmann et al.   CLINICAL CANCER RESEARCH

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

(2020) Alessandro Leal et al.   Nature Communications

Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade

(2020) Qu Zhang et al.   Cancer Discovery

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab

(2020) Guillaume Herbreteau et al.   Journal of Clinical Medicine

Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade

(2019) Andrew Georgiadis et al.   CLINICAL CANCER RESEARCH

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

(2019) Teofila Seremet et al.   Journal of Translational Medicine

Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer

(2019) Nicolas Guibert et al.   LUNG CANCER

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA

(2018) Sarah B. Goldberg et al.   CLINICAL CANCER RESEARCH

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

(2018) Seung Tae Kim et al.   NATURE MEDICINE

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

(2018) Leena Gandhi et al.   NEW ENGLAND JOURNAL OF MEDICINE

A machine learning approach for somatic mutation discovery

(2018) Derrick E. Wood et al.   Science Translational Medicine

Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer

(2018) Valsamo Anagnostou et al.   CANCER RESEARCH

Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer

(2018) Jillian Phallen et al.   CANCER RESEARCH

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

(2017) Lesley Seymour et al.   LANCET ONCOLOGY

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

(2016) Martin Reck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Personalized genomic analyses for cancer mutation discovery and interpretation

(2015) Siân Jones et al.   Science Translational Medicine

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER